SpectraScience, Inc. (OTC: SCIE) is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis, according to their website. SNNLive caught up with Michael Oliver, President and CEO of SpectraScience, Inc. at the Growth Capital Expo 2015 in Las Vegas, NV.
Before getting an update, Mr. Oliver starts off with a brief overview of SpectraScience, a medical device company utilizing light-based technology for the diagnostic market. He then provides an update discussing how in the UK, the National Institute of Health Research, where the company is currently conducting a clinical evaluation of their product, “recently wrote and published to the entire National Health Service, so that’s every hospital in the UK, the advance notice that our product was going to be available for them later this year. Probably will be in the third or fourth quarter, but we’re really excited about the pending approval; because what that does, it allows us to sell our product in every hospital in the National Health Service, and they know it’s been accepted by the government as a standard of care.”
Press release from $SCIE: SpectraScience Announces United Kingdom NHS Technology Alert
As a result of this news, he explains that the company is looking to build a sales team and explore opportunities across Europe. When asked how this affects the company in the US, he states, “Well, it gives us the legitimization that we so badly need for both the market perspective and for investors. Of course, we still have to do an update with FDA as we go from generation three to generation four. This is the fourth generation product that we’re selling in Europe right now.”
Mr. Oliver concludes with his insight about 2015-2016 for the company. For more information about SpectraScience, Inc., go to: www.SpectraScience.com
© 2017 Stock News Now
Supported by Superior Web Solutions